Aparna Govil Bhasker, a Mumbai-based bariatric surgeon, notes that with many manufacturers entering the market, it will be necessary to maintain consistent quality across brands. Our clinical experience at Dharma Diabetes Clinics aligns with this view and we recommend patients stick to established manufacturers with documented Phase III or bioequivalence data
The specific cancer type that prompted the FDA warning represents a tiny fraction of an already uncommon outcome
Eur J Heart Fail 22:14951503 Seferovi PM, Fragasso G, Petrie M, Mullens W, Ferrari R, Thum T, Bauersachs J, Anker SD, Ray R, avuolu Y, Polovina M, Metra M, Ambrosio G, Prasad K, Seferovi J, Jhund PS, Dattilo G, elutkiene J, Piepoli M, Moura B, Chioncel O, Ben Gal T, Heymans S, Jaarsma T, Hill L, Lopatin Y, Lyon AR, Ponikowski P, Lainak M, Jankowska E, Mueller C, Cosentino F, Lund LH, Filippatos GS, Ruschitzka F, Coats AJS, Rosano GMC (2020) Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure
What We Monitor At Centra Internal Medicine, our monitoring goes beyond the scale
In the kidney, GLP-1 receptors are predominantly expressed on vascular smooth muscle cells of the afferent arteriole [63]